Frank Aquila, S&C’s Senior M&A Partner, discussed M&A and private equity across the healthcare sector in a Q&A with Financier Worldwide. He highlighted robust M&A activity in the sector, as well as expectations for growth, given continued innovation in the healthcare industry. “While we have seen transactions across the sector within healthcare, biopharma continues to be the sweet spot with the most high-value transactions.”
In terms of private equity, Frank noted the significant amount of equity such funds have to deploy. “Since PE buyers typically focus on growth sectors, they will continue to focus on healthcare,” he said. “The multibillion-dollar deals over the last year or so clearly demonstrate PE’s appetite for [this] space.”
Frank also mentioned ways in which AI will be a game-changer for the healthcare industry. “[AI], and related technologies, such as machine learning, will drive growth in the near and long term. Technology will lead to new discoveries, which will become available much more quickly than in the past.”
Read the article.